Abbott to Acquire Exact Sciences in $21 Billion Agreement
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
Read More
Search Results for: liver disease
PathAI Integrates PathExplore on AISight Platform for Tumor Analysis
The self-service integration enables users to analyze tumor microenvironments at single-cell resolution using routine H&E slides.
Read More
MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read More
Thermo Fisher Launches Triple-Quad Mass Spectrometer Aimed at High-Throughput Workflows
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
Read More
FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
Read More